As data-driven science, artificial intelligence (AI) has paved a promising path toward an
evolving health system teeming with thrilling opportunities for precision oncology …

Gynecologic (GYN) malignancies are gaining new and much-needed attention, perpetually
fueling literature. Intra-/inter-tumor heterogeneity and “frightened” global distribution by race …

Gynecological cancers including breast, cervical, ovarian, uterine, and vaginal, pose the
greatest threat to world health, with early identification being crucial to patient outcomes and …

Endometrial cancer (EC) is the most common gynecological neoplasm in high-income
countries. Five-year survival rates are related to stage at diagnosis, but currently, no …

With the development of machine learning and deep learning models, artificial intelligence
is now being applied to the field of medicine. In oncology, the use of artificial intelligence for …

Endometrial cancer (EC) is one of the most common malignant tumors in women, and the
increasing incidence and mortality pose a serious threat to the public health. Early diagnosis …

Schistosomiasis is the second most widespread parasitic disease affecting humans. A key
component of today's infection control measures is the diagnosis and monitoring of infection …

Endometrial cancer (EC) is widely known as an aggressive malignancy. Due to the limited
therapeutic options and poor prognosis of patients with advanced-stage EC, there is a need …

Colorectal cancer (CRC) is a high incidence disease, characterized by high morbidity and
mortality rates. Early diagnosis remains challenging because fecal occult blood screening …

Background Endometrial cancer (EC) is one of the most common gynecological cancers.
The traditional diagnosis of EC relies on histopathology, which, however, is invasive and …